Serum VEGF and CFH in Exudative Age-Related Macular Degeneration

REFERENCES

• Ambatti J. Age-related macular degeneration: Etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol. 2003;48:257–293.
   PubMedGoogle Scholar
• Spaide RF, Armstrong D, Browne R. Continuing medical education review: choroidal neovascularisation in age-related macular degeneration-what is the cause? Retina. 2003;23:595–614.
   PubMed Web of Science ®Google Scholar
• Gass JD. Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excisions of subfoveal neovascular membranes. Am J Ophthalmol. 1994;118:285–298.
   PubMed Web of Science ®Google Scholar
• Ishida S, Usui T, Yamashiro K, et al. VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization. J Exp Med. 2003;198:483–489.
   PubMed Web of Science ®Google Scholar
• McColm JR, Geisen P, Hartnett ME. VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: Relevance to clinical ROP. Mol Vis. 2004;10:512–520.
   PubMed Web of Science ®Google Scholar
• Yi X, Ogata N, Komada M, et al. (1997): Vascular endothelial growth factor expression in choroidal neovascularization in rats. Graefes Arch Clin Exp Ophthalmol. 1997;235:313–319.
   PubMed Web of Science ®Google Scholar
• Ferrara N. Vascular endothelial growth factor: Basic science and clinical progress. Endocr Rev. 2004;25:581–611.
   PubMed Web of Science ®Google Scholar
• Nozaki M, Raisler BJ, Sakurai E, et al. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci U S A. 2006;103:2328–2333.
   PubMed Web of Science ®Google Scholar
• Bora PS, Sohn JH, Cruz JM, et al. Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization. J Immunol. 2005;174:491–497.
   PubMed Web of Science ®Google Scholar
• Schlingenmann RO. Role of growth factors and the wound healing response in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2004;242:91–101.
   Google Scholar
• Schlingenmann RO, Van Hinsbergh V. Role of vascular permeability factor/vascular endothelial growth factor in eye diseases. Br J Ophthalmol. 1997;81:501–512.
   Google Scholar
• Zareparsi S, Branham KE, Li M, et al. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am J Hum Genet. 2005;77:149–153.
   PubMed Web of Science ®Google Scholar
• Park JE, Keller GA, Ferrara N. The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell. 1993;4:1317–1326.
   PubMed Web of Science ®Google Scholar
• Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480–1487.
   PubMed Web of Science ®Google Scholar
• Adamis AP, Miller JW, Bernal MT, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol. 1994;118:445–450.
   PubMed Web of Science ®Google Scholar
• Frank RN, Amin RH, Eliott D, et al. Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. Am J Ophthalmol. 1996;122:393–403.
   PubMed Web of Science ®Google Scholar
• Kliffen M, Sharma HS, Mooy CM, et al. Increased expression of angiogenic growth factors in age related maculopathy. Br J Ophthalmol. 1997;81:154–162.
   PubMed Web of Science ®Google Scholar
• Kvanta A, Algvere PV, Berglin L, et al. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Vis Sci. 1996;37:1929–1934.
   PubMed Web of Science ®Google Scholar
• Hattenbach LO, Falk B, Nürnberger F, et al. Detection of inducible nitric oxide synthase and vascular endothelial growth factor in choroidal neovascular membranes. Ophthalmologica. 2002;216:209–214.
   PubMedGoogle Scholar
• Lip P-K, Blann AD, Hope-Ross M, et al. Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology, and endothelial dysfunction. Ophthalmology. 2001;108:705–710.
   PubMed Web of Science ®Google Scholar
• Tsai DC, Charng MJ, Lee FL, et al. Different plasma levels of vascular endothelial growth factor and nitric oxide between patients with choroidal and retinal neovascularization. Ophthalmologica. 2006;220:246–251.
   PubMed Web of Science ®Google Scholar
• Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308:385–389.
   PubMed Web of Science ®Google Scholar
• Edwards AO, Ritter R 3rd, Abel KJ, et al. Complement factor H polymorphism and age-related macular degeneration. Science. 2005;308:421–424.
   PubMed Web of Science ®Google Scholar
• Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005;308:419–421.
   PubMed Web of Science ®Google Scholar
• Hageman GS, Anderson DH, Johnson LV, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A. 2005;102:7227–7232.
   PubMed Web of Science ®Google Scholar
• Magnusson KP, Duan S, Sigurdsson H, et al. CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD. PLoS Med. 2006;3:e5.
   PubMed Web of Science ®Google Scholar
• Sepp T, Khan JC, Thurlby DA, et al. Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers. Invest Ophthalmol Vis Sci. 2006;47:536–540.
   PubMed Web of Science ®Google Scholar
• Wegscheider BJ, Weger M, Renner W, et al. Association of complement factor H Y402H gene polymorphism with different subtypes of exudative age-related macular degeneration. Ophthalmology. 2007;114:738–742.
   Google Scholar
• Steinbrugger I, Haas A, Renner W, et al. Role of the complement component 3 102Gly gene variant in a Central European population with exudative age-related macular degeneration. Spektrum Augenheilkd. 2009;23:353–357.
   Google Scholar